Levosulpiride 12.5mg/ml Injection PCD Franchise in Maharashtra

Levosulpiride 12.5mg/ml Injection Manufacturer in Himachal Pradesh

Levosulpiride Injection 12.5mg/ml PCD Pharma Company in Gujarat

Third Party Manufacturer of Levosulpiride 12.5mg/ml Injection in Punjab

Levosulpiride 12.5mg/ml Injection PCD Supplier in Uttar Pradesh
Exporter of Levosulpiride 12.5mg/ml Injection from India

Home/Products /levosulpiride-12-point-5mg-injection

About the Product

Description


Lesutype 25 Injection contains Levosulpiride (12.5 mg/ml), a prokinetic and antipsychotic agent. It works by enhancing gastrointestinal motility through dopamine D2 receptor antagonism in the gut and also has central anti-dopaminergic activity, helping manage mood and psychomotor symptoms.

It helps in the treatment of gastrointestinal disorders such as nausea, vomiting, bloating, dyspepsia, and irritable bowel syndrome (IBS). It is also used as an adjunct in the management of depression and anxiety-related disorders.

May cause drowsiness, fatigue, dizziness, restlessness, or breast tenderness. Rarely, hormonal imbalances or extrapyramidal symptoms may occur with prolonged use.

Indicated for patients with functional dyspepsia, GERD, delayed gastric emptying, or psychogenic gastrointestinal complaints. Use under strict medical supervision.

Administer only under the supervision of a healthcare professional. Inform your doctor of any history of seizures, hormone-related issues, or psychiatric illness. Not recommended during pregnancy or breastfeeding unless advised by a physician.

Store below 25°C in a cool, dry place, protected from light. Keep out of reach of children. Do not freeze. Use within the prescribed period after opening.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levosulpiride 12.5 mg Injection in the PCD pharma franchise market?

Levosulpiride Injection is used in gastrointestinal disorders such as severe nausea, vomiting, gastric motility disorders, functional dyspepsia, and postoperative gastric complications. It is a strong gastroenterology injectable segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this injection in their product range?

Medical distributors and wholesalers can benefit from consistent demand in hospitals, emergency wards, and gastroenterology departments. It is widely used when oral medication is not suitable, ensuring steady institutional sales and repeat hospital orders.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for injectable and gastro formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this injectable gastro product?

Wholesalers and medical agencies benefit from hospital procurement, emergency usage, inpatient care demand, and gastroenterology prescription flow when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Levosulpiride Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this injectable formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.